988 - A Mental Health Lifeline
988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.
April is Sexual Assault Awareness Month
Sexual Assault Awareness and Prevention Month (SAAPM) works toward the goal of raising public awareness about sexual assault through an annual campaign. This is to help educate communities and individuals regarding the prevention of sexual violence. The first Tuesday in April is the Day of Action and allows for individuals and commuities to take action in preventing against sexual violence.
Sexual Assault Awareness and Prevention Month (SAAPM) is recognized by both civilian and military communities. It is important to acknowledge the importance in educating ourselves and others, along with creating appropriate culture to rid of sexual assault.
The theme for the 2019-2021 SAAPM is "Protecting Our People Protects Our Mission" which speaks volume. The goal is to eliminate sexual assault and spread awareness to educate others.
Here are some websites linked down below on more information regarding this campaign.
https://www.nsvrc.org/saam
https://www.sapr.mil/saapm
You Might Also Enjoy...
TMS and Its Wide Application
FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.
Study Supports the Use of Repetitive TMS for Treatment Resistant Depression
A study in France has found that 1 in 4 individuals may achieve remission for treatment resistant depression with repetitive TMS.
List of TMS Devices that Have Been Cleared by the FDA to Treat Major Depression
Here is a list of TMS devices currently cleared by the FDA to treat major depression.
TMS for Parkinson's Disease
Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.
SAINT Protocol Now Cleared by the FDA
Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).